Keck School of Medicine of USC

Keck School of Medicine of USC

We are dedicated to promoting health, preventing and curing disease, advancing biomedical research and educating tomorrow’s physicians and scientists.

 

HR+HER2- High-Risk eBC: Surveying Efficacy Data of CDK4/6i in the Adjuvant Setting

0 views
February 22, 2021
This video was completed prior to Abemaciclib receiving FDA approval on 10/12/21
Comments 0
Login to view comments. Click here to Login